Entity

Time filter

Source Type


Denoyelle C.,University of Caen Lower Normandy | Denoyelle C.,UNICAEN BioTICLA Unit Biology and innovative therapeutics of locally aggressive cancers EA4656 | Denoyelle C.,Comprehensive Cancer Center Francois Baclesse | Lambert B.,University of Caen Lower Normandy | And 32 more authors.
Cell Death and Disease | Year: 2014

We sought to identify miRNAs that can efficiently induce apoptosis in ovarian cancer cells by overcoming BCL-XL and MCL1 anti-apoptotic activity, using combined computational and experimental approaches. We found that miR-491-5p efficiently induces apoptosis in IGROV1-R10 cells by directly inhibiting BCL-XL expression and by inducing BIM accumulation in its dephosphorylated form. This latter effect is due to direct targeting of epidermal growth factor receptor (EGFR) by miR-491-5p and consequent inhibition of downstream AKTand MAPK signalling pathways. Induction of apoptosis by miR-491-5p in this cell line is mimicked by a combination of EGFR inhibition together with a BH3-mimetic molecule. In contrast, SKOV3 cells treated with miR-491-5p maintain AKT and MAPK activity, do not induce BIM and do not undergo cell death despite BCL-XL and EGFR downregulation. In this cell line, sensitivity to miR-491-5p is restored by inhibition of both AKTand MAPK signalling pathways. Altogether, this work highlights the potential of miRNA functional studies to decipher cell signalling pathways or major regulatory hubs involved in cell survival to finally propose the rationale design of new strategies on the basis of pharmacological combinations. © 2014 Macmillan Publishers Limited. All rights reserved. Source

Discover hidden collaborations